WILMINGTON, Del., March 07, 2017 -- Rigrodsky & Long, P.A.:
Rigrodsky & Long, P.A. announces that it has filed a class action complaint in the United States District Court for the Central District of California on behalf of holders of VCA Inc. (“VCA”) (NASDAQ:WOOF) common stock in connection with the proposed acquisition of VCA by MMI Holdings, Inc., Venice Merger Sub Inc., and Mars, Incorporated (collectively, “Mars”) announced on January 9, 2017 (the “Complaint”). The Complaint, which alleges violations of the Securities Exchange Act of 1934 against VCA, its Board of Directors (the “Board”), and Mars, is captioned Hight v. VCA Inc., Case No. 17-cv-00289 (C.D. Cal.).
If you wish to discuss this action or have any questions concerning this notice or your rights or interests, please contact plaintiff’s counsel, Seth D. Rigrodsky or Gina M. Serra at Rigrodsky & Long, P.A., 2 Righter Parkway, Suite 120, Wilmington, DE 19803, by telephone at (888) 969-4242; by e-mail at [email protected]; or at: http://rigrodskylong.com/investigations/vca-inc-woof/.
On January 7, 2017, VCA entered into an agreement and plan of merger (the “Merger Agreement”) with Mars. Pursuant to the Merger Agreement, VCA shareholders will receive $93.00 per share in cash in a transaction valued at approximately $9.1 billion (the “Proposed Transaction”).
Among other things, the Complaint alleges that, in an attempt to secure shareholder support for the Proposed Transaction, defendants issued materially incomplete disclosures in a proxy statement (the “Proxy Statement”) filed with the United States Securities and Exchange Commission on February 3, 2017. The Proxy Statement, which recommends that VCA stockholders vote in favor of the Proposed Transaction, omits material information necessary to enable shareholders to make an informed decision as to how to vote on the Proposed Transaction, including material information with respect to VCA’s financial projections and the opinions and analyses of VCA’s financial advisor. The Complaint seeks injunctive and equitable relief and damages on behalf of holders of VCA common stock.
If you wish to serve as lead plaintiff, you must move the Court no later than May 8, 2017. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Any member of the proposed class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member.
Rigrodsky & Long, P.A., with offices in Wilmington, Delaware and Garden City, New York, regularly prosecutes securities fraud, shareholder corporate, and shareholder derivative litigation on behalf of shareholders in state and federal courts throughout the United States.
Attorney advertising. Prior results do not guarantee a similar outcome.
CONTACT: Rigrodsky & Long, P.A. Seth D. Rigrodsky Gina M. Serra (888) 969-4242 (302) 295-5310 Fax: (302) 654-7530 [email protected] http://www.rigrodskylong.com


Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round 



